According to Amryt Pharma's latest financial reports the company has $83.25 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2021-12-31 | $0.11 B | -4.89% |
2020-12-31 | $0.11 B | 81.87% |
2019-12-31 | $65.19 M | 407.81% |
2018-12-31 | $12.83 M | -56.54% |
2017-12-31 | $29.54 M | 222.62% |
2016-12-31 | $9.15 M | |
2015-03-31 | $18.18 M | -24.13% |
2014-03-31 | $23.96 M | -40.6% |
2013-03-31 | $40.34 M | 12561.07% |
2012-03-31 | $0.31 M | 13942.31% |
2011-03-31 | $0 M |